Literature DB >> 18378865

Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population.

Bradley N Gaynes1, Brian Wells Pence, Joseph J Eron, William C Miller.   

Abstract

OBJECTIVE: To study the prevalence of psychiatric comorbidity based on reference standard diagnostic criteria in patients with human immunodeficiency virus (HIV). Psychiatric illness is common in patients with HIV and has been associated with negative health behaviors and poorer clinical outcomes. Among those persons with psychiatric illness, psychiatric comorbidity (multiple simultaneous diagnoses) is associated with increased psychiatric severity and higher HIV risk behaviors.
METHODS: A total of 152 consecutively presenting HIV+ patients at an academic medical center in the southeastern US completed a modified Structured Clinical Interview for DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4(th) Edition) that assessed mood, anxiety, and substance use disorders in the past year and past month.
RESULTS: Fifty percent and 33% of patients had a past-year and past-month diagnosis, respectively. The most common diagnoses were mood disorders (32% past year/21% past month) followed by anxiety (21%/17%) and substance use disorders (22%/11%). Half of those with past-year disorders and 40% of those with past-month disorders met the criteria for multiple diagnoses. Of those with a mood disorder in the past month, 53% also had an anxiety or substance use disorder; of those with an anxiety disorder, 62% also had a mood or substance use disorder; and of those with a substance use disorder, 63% also had a mood or anxiety disorder. Psychiatric comorbidity was associated with younger age, White non-Hispanic race/ethnicity, and greater HIV symptomatology.
CONCLUSIONS: Comorbidity of mood, anxiety, and substance use disorders was the exception rather than the rule in this sample. Potential co-occurring disorders should be considered for HIV+ patients presenting with a psychiatric diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18378865      PMCID: PMC2900836          DOI: 10.1097/PSY.0b013e31816aa0cc

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  42 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

2.  Meta-analysis of the relationship between HIV infection and risk for depressive disorders.

Authors:  J A Ciesla; J E Roberts
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

Review 3.  The effects of stressful life events, coping, and cortisol on HIV infection.

Authors:  Jane Leserman
Journal:  CNS Spectr       Date:  2003-01       Impact factor: 3.790

4.  Telephone versus in-person surveys of community health status.

Authors:  C S Aneshensel; R R Frerichs; V A Clark; P A Yokopenic
Journal:  Am J Public Health       Date:  1982-09       Impact factor: 9.308

5.  Measuring depression in the community: a comparison of telephone and personal interviews.

Authors:  C S Aneshensel; R R Frerichs; V A Clark; P A Yokopenic
Journal:  Public Opin Q       Date:  1982

6.  Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers.

Authors:  C D Sherbourne; K B Wells; L S Meredith; C A Jackson; P Camp
Journal:  Arch Gen Psychiatry       Date:  1996-10

Review 7.  HIV disease progression: depression, stress, and possible mechanisms.

Authors:  Jane Leserman
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

Review 8.  Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.

Authors:  Michael J Ostacher
Journal:  Psychiatr Clin North Am       Date:  2007-03

9.  Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.

Authors:  Jean-Jacques Parienti; Véronique Massari; Diane Descamps; Astrid Vabret; Elisabeth Bouvet; Bernard Larouzé; Renaud Verdon
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

10.  Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people.

Authors:  Frank H Galvan; M Audrey Burnam; Eric G Bing
Journal:  J Psychoactive Drugs       Date:  2003-05
View more
  56 in total

1.  Subjective wellbeing and ‘felt’ stigma when living with HIV.

Authors:  Vicki E Hutton; RoseAnne Misajon; Francesca E Collins
Journal:  Qual Life Res       Date:  2013-02       Impact factor: 4.147

Review 2.  Future directions for interventions targeting PTSD in HIV-infected adults.

Authors:  Allison J Applebaum; C Andres Bedoya; Ellen S Hendriksen; Jesse L Wilkinson; Steven A Safren; Conall O'Cleirigh
Journal:  J Assoc Nurses AIDS Care       Date:  2014-11-10       Impact factor: 1.354

3.  Specific psychiatric correlates of acute care utilization among unstably housed HIV-positive adults.

Authors:  Maggie Chartier; Adam W Carrico; Sheri D Weiser; Margot B Kushel; Elise D Riley
Journal:  AIDS Care       Date:  2012-04-25

Review 4.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

5.  Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2017-04

6.  Perinatal depressive symptoms in HIV-infected versus HIV-uninfected women: a prospective study from preconception to postpartum.

Authors:  Leah H Rubin; Judith A Cook; Dennis D Grey; Kathleen Weber; Christina Wells; Elizabeth T Golub; Rodney L Wright; Rebecca M Schwartz; Lakshmi Goparaju; Deborah Cohan; Melissa L Wilson; Pauline M Maki
Journal:  J Womens Health (Larchmt)       Date:  2011-07-06       Impact factor: 2.681

7.  Abstracts of the HIV Drug Therapy in the Americas 8-10 May 2014, Rio de Janeiro, Brazil.

Authors: 
Journal:  J Int AIDS Soc       Date:  2014-05-07       Impact factor: 5.396

8.  Mental health treatment to reduce HIV transmission risk behavior: a positive prevention model.

Authors:  Kathleen J Sikkema; Melissa H Watt; Anya S Drabkin; Christina S Meade; Nathan B Hansen; Brian W Pence
Journal:  AIDS Behav       Date:  2010-04

9.  The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States.

Authors:  Bethany L DiPrete; Brian W Pence; Angela M Bengtson; Richard D Moore; David J Grelotti; Conall O'Cleirigh; Riddhi Modi; Bradley N Gaynes
Journal:  AIDS Behav       Date:  2019-03

10.  Stress biomarkers as outcomes for HIV+ prevention: participation, feasibility and findings among HIV+ Latina and African American mothers.

Authors:  Dorie A Glover; Elena F Garcia-Aracena; Patricia Lester; Eric Rice; Mary Jane Rothram-Borus
Journal:  AIDS Behav       Date:  2009-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.